Abstract 3‐(2‐Di‐n‐propylaminoethyl)pyrrole (1a) was prepared in good yield by reduction of pyrrole‐3‐(N,N‐di‐n‐propylglyoxamide) (9) with lithium aluminum hydride. 3‐(2‐Di‐n‐propylaminoethyl)‐5‐acetylpyrrole (1b) was prepared by first acetylation of 1‐p‐toluenesulfonyl‐3‐(2‐di‐n‐propylaminoethyl)pyrrole (6) followed by hydrolysis of the p‐toluenesulfonyl substituent. The starting material 6 was prepared by homologation of 1‐(p‐toluenesulfonyl)pyrrole‐3‐carboxaldehyde (3) to the corresponding acetaldehyde followed by reductive amination of the latter.
No takes yet. Share an insight, caveat, or question.
Vassilis J. Demopoulos (1988) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: